Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia

The ε4 allele of the apolipoprotein E gene (APOE4) has been consistently associated with a greater risk of Alzheimer's disease (AD) as well as an earlier onset of AD. It is possible that APOE4 may also play a role in the etiology of other neurodegenerative disorders, such as Parkinson's disease (PD). APOE genotype, age of onset, disease duration, smoking history, and dementia status were collected for families with PD, yielding 324 Caucasian families with complete information. Logistic regression employing one individual per family and including age of onset and disease duration as covariates demonstrated a significantly increased risk of dementia for those individuals having inherited at least one ε4 allele (OR = 3.37; P = 0.002). Survival analyses also demonstrated a significantly earlier age of onset for those subjects with at least one ε4 allele (59.7 years) as compared with those homozygous for the more common ε3 allele (62.4 years; P = 0.009). Thus, consistent with previous studies, we find evidence that the presence of an ε4 allele results in significantly earlier onset of PD and a greater likelihood of dementia. It appears the similarities between PD and AD may be due to an overlap in the diseases' genetic etiology. © 2005 Movement Disorder Society

[1]  E. Larson,et al.  Effect of Education on the Mini‐Mental State Examination as a Screening Test for Dementia , 1991, Journal of the American Geriatrics Society.

[2]  A. Lees,et al.  What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.

[3]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[4]  W. Koller,et al.  When does Parkinson's disease begin? , 1992, Neurology.

[5]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[6]  D R Rajput,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[7]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[8]  D. Clair,et al.  Apolipoprotein E ϵ4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls , 1994, Neuroscience Letters.

[9]  A. Brookes,et al.  Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. , 1994, Neuroscience letters.

[10]  B. Hyman,et al.  Alzheimer's disease with and without coexisting Parkinson's disease changes , 1995, Neurology.

[11]  G. Schellenberg,et al.  Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes , 1997, Annals of neurology.

[12]  J. Chapman,et al.  Apolipoprotein E4 in Parkinson Disease and Dementia: New Data and Meta‐Analysis of Published Studies , 1998, Alzheimer disease and associated disorders.

[13]  A. Quattrone,et al.  Apolipoprotein E polymorphisms and Parkinson's disease , 1999, Neuroscience Letters.

[14]  A. Hofman,et al.  APOE and the risk of PD with or without dementia in a population-based study , 2000, Neurology.

[15]  D. Schaid,et al.  Case‐control study of debrisoquine 4‐hydroxylase, n‐acetyltransferase 2, and apolipoprotein e gene polymorphisms in Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[16]  J. Nutt,et al.  Age at onset of Parkinson disease and apolipoprotein E genotypes. , 2002, American journal of medical genetics.

[17]  L. Seeberger,et al.  Linkage stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's disease families , 2002, Journal of medical genetics.

[18]  J. Perlmutter,et al.  Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset. , 2002, Genomics.

[19]  T. Foroud,et al.  Reliability of reported age at onset for Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.

[20]  M. Emre Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.

[21]  J. Haines,et al.  Apolipoprotein E controls the risk and age at onset of Parkinson disease , 2004, Neurology.

[22]  S. Lipton,et al.  Molecular pathways to neurodegeneration , 2004, Nature Medicine.

[23]  J. Brandt,et al.  Motor signs during the course of Alzheimer disease , 2004, Neurology.

[24]  Yaakov Stern,et al.  Cognitive reserve: Implications for diagnosis and prevention of Alzheimer’s disease , 2004, Current Neurology and Neuroscience Reports.

[25]  T. Foroud,et al.  Genetics of Parkinson disease , 2004 .

[26]  O. Lopez,et al.  Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease , 2005, Neurology.